fumonisin-b1 and Leukemia--Myeloid

fumonisin-b1 has been researched along with Leukemia--Myeloid* in 1 studies

Other Studies

1 other study(ies) available for fumonisin-b1 and Leukemia--Myeloid

ArticleYear
Induction of apoptosis and potentiation of ceramide-mediated cytotoxicity by sphingoid bases in human myeloid leukemia cells.
    The Journal of biological chemistry, 1996, Apr-05, Volume: 271, Issue:14

    Prior studies demonstrated that ceramide promotes apoptotic cell death in the human myeloid leukemia cell lines HL-60 and U937 (Jarvis, W. D., Kolesnick, R. N., Fornari, F. A., Jr., Traylor, R. S., Gewirtz, D. A., and Grant, S. (1994) Proc. Natl. Acad. Sci. U. S. A. 91, 73-77), and that this lethal process is potently suppressed by diglyceride (Jarvis, W. D., Fornari, F. A., Jr., Browning, J. L., Gewirtz, D. A., Kolesnick, R. N., and Grant, S. (1994) J. Biol. Chem. 269, 31685-31692). The present findings document the intrinsic ability of sphingoid bases to induce apoptosis in HL-60 and U937 cells. Exposure to either sphingosine or sphinganine (0. 001 10 microM) for 6 h promoted apoptotic degradation of genomic DNA as indicated by (a) electrophoretic resolution of 50-kilobase pair DNA loop fragments and 0.2-1.2-kilobase pair DNA fragment ladders on agarose gels, and (b) spectrofluorophotometric determination of the formation and release of double-stranded fragments and corresponding loss of integrity of bulk DNA. DNA damage correlated directly with reduced cloning efficiency and was associated with the appearance of apoptotic cytoarchitectural traits. At sublethal concentrations (

    Topics: Apoptosis; Ceramides; Diglycerides; DNA Damage; Enzyme Inhibitors; Fumonisins; HL-60 Cells; Humans; Leukemia, Myeloid; Mycotoxins; Protein Kinase C; Sphingomyelin Phosphodiesterase; Sphingosine; Stereoisomerism; Structure-Activity Relationship

1996